摘要
目的探讨豆蔻酰佛波醇乙酯(PMA)和γ干扰素(γIFN)在卵巢癌及其他肿瘤治疗中的意义。方法用PMA+γIFN处理的卵巢癌细胞及其他肿瘤细胞用流式细胞仪检测免疫球蛋白超家族糖蛋白的共刺激分子B7-1、主要组织相容抗原(MHCⅠ、MHCⅡ)的表达情况。并采用51铬(51Cr)4小时释放试验及[3H]胸腺嘧啶渗入法了解B7-1的表达对细胞毒性T淋巴细胞(CTL)杀伤活性和对T淋巴细胞增殖的诱导情况。结果预先用PMA处理,后用γIFN处理的肿瘤细胞,能诱导B7-1表达阳性的伯基特淋巴瘤细胞株或转染B7-1基因的卵巢粘液性囊腺癌细胞的B7-1表达增强,能诱导无B7-1、MHCⅠ、MHCⅡ表达的卵巢癌细胞株及其他肿瘤细胞株表达B7-1及MHCⅠ、MHCⅡ,而单独用γIFN则不能诱导B7-1表达。PMA和γIFN的这种协同效应能被蛋白激酶抑制剂1(5磺酰基)异喹啉2甲基哌嗪盐酸盐(H7)阻断。被诱导表达的B7-1能激活CTL的杀伤活性,并能增强T淋巴细胞的增殖能力。结论γIFN诱导的B7-1的表达可能依赖于PMA预先激活蛋白激酶C。诱导B7-1等的表达对治疗肿瘤有一定的价值。
Objective To investigate the therapeutic potential of phorbol12myristate13acetate(PMA) and interferon(IFN) by induction of expression of adhesion molecule in mucious cystadenocarcinoma of ovary(MCAS) and other tumor cells. Methods Expression of costimulatory signals(B7-1), major histocompatibility complex(MHCMHC) was analysed with flow cytometry. Cytotoxic T lymphocytes(CTL) killing activity and T cell proliferation induced with expression of B7-1 were evaluated by 4h51Cr release assay and standard3 HTdR incorporation and scintitation counting. Results Pretreatment with PMA and then treated with IFN was able to enhance B7-1 expresssion on the tumor cell lines with the constitutive B7-1 expression or on B7-1-transfected tumor cells and to induce B7-1 expression on MCAS and some tumor cell lines without constitutive B7-1 expression. However, treament with IFN alone failed to induce B7-1 expression on the tumor cell lines. The synergistic effect of PMA combined with IFN in the induction of B7-1 expression can be anatagonised by H7 lfonyl)2methylPiperazine dihydrochloride]. In addition, treatment with PMA combined with IFN simultaneously induced or enhanced the expression of MHC class / on these tumor cell lines. The tumor cells treated by PMA combined with IFN were able to induce CTL killing activity and T cell proliferation, which is involved in the expression of B7-1. Conclusions The enhancement or induction of B7-1 expression by IFN may be dependent on the prior activation of protein kinase by PMA and the induced B7-1 expression on tumor cells may have some therapeutic potential.
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
1999年第7期414-416,共3页
Chinese Journal of Obstetrics and Gynecology
基金
国家自然科研基金
国家杰出青年科研基金
关键词
卵巢肿瘤
PMA
十四酰佛波乙酯
Γ-干扰素
Interferon type Antigens
CD80TlymphocytesLymphocyte transformationPhorbol myristale acetate